Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001753530 | SCV001986219 | uncertain significance | not provided | 2020-05-29 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25344692) |
Labcorp Genetics |
RCV001753530 | SCV003444608 | uncertain significance | not provided | 2023-06-30 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The glycine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 162404). This missense change has been observed in individual(s) with clinical features of microcephaly and chorioretinopathy (PMID: 25344692). This variant is present in population databases (rs368449236, gnomAD 0.007%). This sequence change replaces glutamic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 849 of the TUBGCP6 protein (p.Glu849Gly). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
OMIM | RCV000149799 | SCV000196608 | pathogenic | Microcephaly and chorioretinopathy 1 | 2014-12-01 | no assertion criteria provided | literature only |